Approximately 904,000 newborns die of breathing complications, or birth asphyxia, each year[1]. It is estimated that 30% of these deaths could be prevented[2]; however, healthcare workers in developing nations often lack the training, skills, or equipment necessary to properly resuscitate these infants. For this reason, child mortality is disproportionally clustered in low-resource locations in which the current standard of care is ineffective. The bag-valve mask resuscitator (or BVM) is the recommended treatment for a newborn who is not breathing properly.

This content is only available via PDF.
You do not currently have access to this content.